Therapy & Research
WHAT’S NEW
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
The Drug Enforcement Administration (DEA) last week proposed increasing its 2024 production quotas for research-grade psychedelic ...
POPULAR ARTICLES
Another Michigan City Approves Psychedelics Decriminalization As Activists Pursue Statewide Ballot Measure
Yet another Michigan city has moved to decriminalize psychedelics like psilocybin and ibogaine as activists continue to pursue a b...
Read More
Muscimol & Psilocybin: Why Are Some Magic Mushrooms Legal and Others Illegal?
An introduction to the disjointed drug policy around psychoactive mushrooms....
Read More
Are Psychedelic Studies Making an Academic Comeback?
The field of therapeutic psychedelics research is attracting multi-million dollar investments from private donors....
Read More
Advanced brain imaging study hints at how DMT alters perception of reality
Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain activity....
Read More
MDMA for PTSD study: Veteran shares experience
A clinical trial studying the effects of the drug on those who suffer from post-traumatic stress disorder has seen promising resul...
Read More
Psilocybin therapy appears to be at least as effective as a leading conventional antidepressant
Psilocybin, the active compound in magic mushrooms, may be at least as effective as selective serotonin reuptake inhibitors, the l...
Read More